Pulmatrix (PULM) EPS (Weighted Average and Diluted) (2022 - 2025)
Pulmatrix's EPS (Weighted Average and Diluted) history spans 4 years, with the latest figure at -$0.25 for Q4 2025.
- For Q4 2025, EPS (Weighted Average and Diluted) rose 54.55% year-over-year to -$0.25; the TTM value through Dec 2025 reached -$1.41, up 46.18%, while the annual FY2025 figure was -$1.41, 46.18% up from the prior year.
- EPS (Weighted Average and Diluted) for Q4 2025 was -$0.25 at Pulmatrix, up from -$1.24 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.5 in Q1 2025 and bottomed at -$1.59 in Q2 2024.
- The 4-year median for EPS (Weighted Average and Diluted) is -$0.71 (2024), against an average of -$0.7.
- The largest annual shift saw EPS (Weighted Average and Diluted) plummeted 75133.98% in 2023 before it soared 118.85% in 2024.
- A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$1.14 in 2022, then skyrocketed by 50.0% to -$0.57 in 2023, then increased by 3.51% to -$0.55 in 2024, then surged by 54.55% to -$0.25 in 2025.
- Per Business Quant, the three most recent readings for PULM's EPS (Weighted Average and Diluted) are -$0.25 (Q4 2025), -$1.24 (Q3 2025), and -$0.42 (Q2 2025).